Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 699

Advisorymandi accepts $36m from EST

The financial advisory services provider plans to use EST's investment to launch a financial education arm and build a multilingual investment platform.

Sep 6, 2019

Sourcewater filters through $7.2m

Oilfield water management company Sourcewater secured series A funding from backers including Marubeni and Bison having launched from MIT’s Energy Ventures program in 2014.

Sep 6, 2019

T-Rex collects $15m

Citi co-led a $15m round for the investment risk management software producer that also featured returning investor Innogy.

Sep 5, 2019

Neura lures corporates to $16m series B

The app engagement software developer raised the funding in a Liberty Technology Venture Capital-led round featuring Amdocs and existing investor Axa.

Sep 5, 2019

Passage Bio packs in another $110m

University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.

Sep 5, 2019

Federated Wireless connects to $51m series C

The telecommunications spectrum provider has now raised $120m altogether, SBA Communications and American Tower contributing to its latest round.

Sep 5, 2019

Cartica AI clinches series B funding

Cartica AI, an autonomous perception tech developer forged from Technion spinout Cortica, secured capital from OurCrowd, Continental, Toyota and BMW in what appears to be its first publicly-disclosed round.

Sep 5, 2019

Ginger jumps to $35m series C

MIT Media Lab spinout Ginger has raised $35m as it looks to further develop its mental and emotional health support app.

Sep 5, 2019

Juul's convertible debt round reaches $785m

Altria-backed e-cigarette brand Juul has added $460m to a convertible note round it plans to close at $800m according to a securities filing.

Sep 5, 2019

Nkarta inks $114m series B deal

Nkarta, which is developing cell therapy treatments for cancer, has emerged from stealth with $114m in a round featuring Novo, Amgen Ventures and SR One.

Sep 5, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here